On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
All content for Brains Behind AI is the property of Ari Yacobi and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
Seekar: Kordel France on building a fast - growing AI platform with 3 successful medical products
Brains Behind AI
37 minutes
4 years ago
Seekar: Kordel France on building a fast - growing AI platform with 3 successful medical products
On our 29th Episode of “Brains Behind AI”, Ari and Natalie sat down with CEO and Co-Founder of Seekar Technologies, KordelFrance. Seekar Technologies is a technology startup that builds Artificial Intelligence products for a variety of industries. In response to the COVID-19 pandemic, learn how Seekar contributed two products free of charge to physicians to help ease demand on medical staffing and screening for the virus faster, making a huge splash in the medical industry. Kordel also walks ...
Brains Behind AI
On this episode of Brains Behind AI, Ari had the opportunity to chat with Dr. Abraham Heifets, the CEO and Co-Founder of Atomiwse, where he invented the use of deep convolutional neural networks for drug discovery. Abe’s doctoral work applied machine learning and classical AI techniques to organic synthesis planning, which is a long-standing challenge in chemistry. His vision of Artificial Intelligence bringing better, safe, and more potent drugs to patients has become a reality, and Atomwise...
